Effect of erlotinib on CYP3A activity, evaluated in vitro and by dual probes in patients with cancer.

Calvert, Hilary; Twelves, Chris; Ranson, Malcolm; Plummer, Ruth; Fettner, Scott; Pantze, Michael; Ling, Jie; Hamilton, Marta; Lum, Bert L; Rakhit, Ashok.
Anticancer Drugs; 25(7): 832-40, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24637575